Cannabis use in young people: The risk for schizophrenia

被引:131
作者
Casadio, Paola [1 ]
Fernandes, Cathy [2 ]
Murray, Robin M. [2 ]
Di Forti, Marta [2 ]
机构
[1] AUSL Ravenna, Dept Mental Hlth, Faenza, RA, Italy
[2] Inst Psychiat, London SE5 8AF, England
基金
英国医学研究理事会;
关键词
Adolescence; Cannabis; Schizophrenia; Psychosis; Risk factors; Epidemiology; Animal models; PUBERTAL MATURATION IMPLICATIONS; HETEROZYGOUS NEUREGULIN-1 MICE; MESSENGER-RNA EXPRESSION; PSYCHOTIC SYMPTOMS; COGNITIVE DEFICITS; RECOGNITION MEMORY; ADULT RATS; CLINICAL CHARACTERISTICS; VAL(158)MET MODERATION; DIFFERENTIALLY AFFECTS;
D O I
10.1016/j.neubiorev.2011.04.007
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Cannabis is one of the most commonly used illicit drugs, and despite the widely held belief that it is a safe drug, its long-term use has potentially harmful consequences. To date, the research on the impact of its use has largely been epidemiological in nature and has consistently found that cannabis use is associated with schizophrenia outcomes later in life, even after controlling for several confounding factors. While the majority of users can continue their use without adverse effects, it is clear from studies of psychosis that some individuals are more vulnerable to its effects than others. In addiction, evidence from both epidemiological and animal studies indicates that cannabis use during adolescence carries particular risk. Further studies are warranted given the increase in the concentration of the main active ingredient (Delta(9)-tetrahydrocannabinol) in street preparations of cannabis and a decreasing age of first-time exposure to cannabis. (c) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1779 / 1787
页数:9
相关论文
共 133 条
[31]   Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia [J].
Dekker, Nienke ;
Schmitz, Nicole ;
Peters, Bart D. ;
van Amelsvoort, Therese A. ;
Linszen, Don H. ;
de Haan, Lieuwe .
PSYCHIATRY RESEARCH-NEUROIMAGING, 2010, 181 (01) :51-56
[32]  
DEVANE WA, 1988, MOL PHARMACOL, V34, P605
[33]   ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR [J].
DEVANE, WA ;
HANUS, L ;
BREUER, A ;
PERTWEE, RG ;
STEVENSON, LA ;
GRIFFIN, G ;
GIBSON, D ;
MANDELBAUM, A ;
ETINGER, A ;
MECHOULAM, R .
SCIENCE, 1992, 258 (5090) :1946-1949
[34]   High-potency cannabis and the risk of psychosis [J].
Di Forti, Marta ;
Morgan, Craig ;
Dazzan, Paola ;
Pariante, Carmine ;
Mondelli, Valeria ;
Marques, Tiago Reis ;
Handley, Rowena ;
Luzi, Sonija ;
Russo, Manuela ;
Paparelli, Alessandra ;
Butt, Alexander ;
Stilo, Simona A. ;
Wiffen, Ben ;
Powell, John ;
Murray, Robin M. .
BRITISH JOURNAL OF PSYCHIATRY, 2009, 195 (06) :488-491
[35]   The endocannabinoid system and its therapeutic exploitation [J].
Di Marzo, V ;
Bifulco, M ;
De Petrocellis, L .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (09) :771-784
[36]   Multimethod alexithymia assessment in adolescents and young adults with a cannabis use disorder [J].
Dorard, Geraldine ;
Berthoz, Sylvie ;
Haviland, Mark G. ;
Phan, Olivier ;
Corcos, Maurice ;
Bungener, Catherine .
COMPREHENSIVE PSYCHIATRY, 2008, 49 (06) :585-592
[37]   Affect dysregulation in cannabis abusers - A study in adolescents and young adults [J].
Dorard, Geraldine ;
Berthoz, Sylvie ;
Phan, Olivier ;
Corcos, Maurice ;
Bungener, Catherine .
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2008, 17 (05) :274-282
[38]   Cannabis use predicts future psychotic symptoms, and vice versa [J].
Ferdinand, RF ;
Sondeijker, F ;
van der Ende, J ;
Selten, JP ;
Huizink, A ;
Verhulst, FC .
ADDICTION, 2005, 100 (05) :612-618
[39]   Cannabis use and patterns of psychotic symptomatology in a longitudinal birth cohort [J].
Cant, Nicole ;
Buchanan, Mary ;
Carr, Anitra C. ;
Boden, Joseph M. .
NEW ZEALAND MEDICAL JOURNAL, 2022, 135 (1562) :25-33
[40]   Cannabis dependence and psychotic symptoms in young people [J].
Fergusson, DM ;
Horwood, LJ ;
Swain-Campbell, NR .
PSYCHOLOGICAL MEDICINE, 2003, 33 (01) :15-21